FDA Adverse Event
Injury
Summary report: N
ENFORM INTRAPERITONEAL MESH
MDR report key: 24604380
·
Received March 16, 2026
Report
- Report Number
- MW5185226
- Event Type
- Injury
- Date Received
- March 16, 2026
- Date of Event
- December 10, 2024
- Report Date
- March 6, 2026
- Manufacturer
- W. L. GORE & ASSOCIATES, INC.
- Product Code
- OWZ
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- FL, US
- Reporter Occupation
- PATIENT
- Health Professional
- *
Narratives
Description of Event or Problem · 0
INTRAPERITONEAL, (B)(6) 2024. HAVE NOT BEEN ABLE TO EAT ANY TYPE OF SOLID FOOD SINCE THAT SURGERY. SEVERE STRICTURE AT THE GE JUNCTION WHERE MESH WAS PLACED. 16 EGDS WITH DILATION AND AN ABORTED/FAILED REVISION SURGERY IN (B)(6) 2026, WHICH FOUND EXTENSIVE ADHESIONS, MAKING IT IMPOSSIBLE TO COMPLETE THE REVISION SURGERY. I NOW HAVE A GASTRIC FEEDING TUBE FOR NUTRITION. ALL BIOPSY REPORTS ON GASTRIC AND ESOPHAGEAL TISSUE NEG.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 663343 | ENFORM INTRAPERITONEAL MESH | MESH, SURGICAL, ABSORBABLE, THORACIC, CHEST WALL RECONSTRUCTION | OWZ | W. L. GORE & ASSOCIATES, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 73 YR | Female | Hospitalization| S | ATORVASTATIN 20 MG QD.| MERTAZAPINE 15 MG QHS.| SERTRALINE 100 MG QHS. |